APO Research
Talk to an analyst

APO RESEARCH · REPORT

Aquaporin

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Aquaporin Market Outlook and Growth Opportunities 2026

2 January 2026197 pages

Choose your research edition.

Industry ResearchAquaporin Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Aquaporin Industry Growth and Trends Forecast to 203289 pages · $3,450 USDMarket StructureGlobal Aquaporin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Aquaporin Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Aquaporin Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Aquaporin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Aquaporin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Aquaporin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Aquaporin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Aquaporin market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Aquaporin market include Merck KGaA, Santa Cruz Biotechnology, Proteintech Group, Boster Biological Technology, Bio-Techne, Bio-Rad Laboratories, Alomone Labs, Abcam and Abbexa, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Aquaporin market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Aquaporin and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Aquaporin revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Aquaporin market.

Aquaporin Segment by Company

Merck KGaA

Santa Cruz Biotechnology

Proteintech Group

Boster Biological Technology

Bio-Techne

Bio-Rad Laboratories

Alomone Labs

Abcam

Abbexa

Aquaporin Segment by Type

Anti-Aquaporin Antibody

Aquaporin Channel Blocker

Other

Aquaporin Segment by Application

Purification Of Water

Research

Medicine

Other

Aquaporin Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Aquaporin status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Aquaporin key companies, revenue, market share, and recent developments.

3. To split the Aquaporin breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Aquaporin market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Aquaporin significant trends, drivers, influence factors in global and regions.

6. To analyze Aquaporin competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Aquaporin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Aquaporin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Aquaporin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Aquaporin industry.

Chapter 3: Detailed analysis of Aquaporin company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Aquaporin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Aquaporin in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Aquaporin Industry Trends Table 2. Aquaporin Industry Drivers Table 3. Aquaporin Industry Opportunities and Challenges Table 4. Aquaporin Industry Restraints Table 5. Global Aquaporin Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Aquaporin Revenue Share by Company (2021-2026) Table 7. Global Aquaporin Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Aquaporin Key Company Manufacturing Base & Headquarters Table 9. Global Aquaporin Company, Product Type & Application Table 10. Global Aquaporin Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Aquaporin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Anti-Aquaporin Antibody Table 15. Significant Companies of Aquaporin Channel Blocker Table 16. Significant Companies of Other Table 17. Global Aquaporin Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Aquaporin Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Aquaporin Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Aquaporin Sales Value Share by Type (2021-2026) Table 21. Global Aquaporin Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Purification Of Water Table 23. Significant Companies of Research Table 24. Significant Companies of Medicine Table 25. Significant Companies of Other Table 26. Global Aquaporin Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Aquaporin Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Aquaporin Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Aquaporin Sales Value Share by Application (2021-2026) Table 30. Global Aquaporin Sales Value Share by Application (2027-2032) Table 31. Global Aquaporin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Aquaporin Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Aquaporin Sales Value Share by Region (2021-2026) Table 34. Global Aquaporin Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Aquaporin Sales Value Share by Region (2027-2032) Table 36. Global Aquaporin Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Aquaporin Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Aquaporin Sales Value Market Share by Country (2021-2026) Table 39. Global Aquaporin Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Aquaporin Sales Value Market Share by Country (2027-2032) Table 41. Merck KGaA Company Information Table 42. Merck KGaA Business Overview Table 43. Merck KGaA Aquaporin Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Merck KGaA Aquaporin Product Portfolio Table 45. Merck KGaA Recent Development Table 46. Santa Cruz Biotechnology Company Information Table 47. Santa Cruz Biotechnology Business Overview Table 48. Santa Cruz Biotechnology Aquaporin Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Santa Cruz Biotechnology Aquaporin Product Portfolio Table 50. Santa Cruz Biotechnology Recent Development Table 51. Proteintech Group Company Information Table 52. Proteintech Group Business Overview Table 53. Proteintech Group Aquaporin Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Proteintech Group Aquaporin Product Portfolio Table 55. Proteintech Group Recent Development Table 56. Boster Biological Technology Company Information Table 57. Boster Biological Technology Business Overview Table 58. Boster Biological Technology Aquaporin Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Boster Biological Technology Aquaporin Product Portfolio Table 60. Boster Biological Technology Recent Development Table 61. Bio-Techne Company Information Table 62. Bio-Techne Business Overview Table 63. Bio-Techne Aquaporin Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Bio-Techne Aquaporin Product Portfolio Table 65. Bio-Techne Recent Development Table 66. Bio-Rad Laboratories Company Information Table 67. Bio-Rad Laboratories Business Overview Table 68. Bio-Rad Laboratories Aquaporin Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Bio-Rad Laboratories Aquaporin Product Portfolio Table 70. Bio-Rad Laboratories Recent Development Table 71. Alomone Labs Company Information Table 72. Alomone Labs Business Overview Table 73. Alomone Labs Aquaporin Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Alomone Labs Aquaporin Product Portfolio Table 75. Alomone Labs Recent Development Table 76. Abcam Company Information Table 77. Abcam Business Overview Table 78. Abcam Aquaporin Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Abcam Aquaporin Product Portfolio Table 80. Abcam Recent Development Table 81. Abbexa Company Information Table 82. Abbexa Business Overview Table 83. Abbexa Aquaporin Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Abbexa Aquaporin Product Portfolio Table 85. Abbexa Recent Development Table 86. Research Programs/Design for This Report Table 87. Authors List of This Report Table 88. Secondary Sources Table 89. Primary Sources List of Figures Figure 1. Aquaporin Product Image Figure 2. Global Aquaporin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Aquaporin Market Size (2021-2032) & (US$ Million) Figure 4. Global Aquaporin Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Anti-Aquaporin Antibody Image Figure 8. Aquaporin Channel Blocker Image Figure 9. Other Image Figure 10. Global Aquaporin Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Aquaporin Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Aquaporin Sales Value Share by Type (2021-2032) Figure 13. Purification Of Water Image Figure 14. Research Image Figure 15. Medicine Image Figure 16. Other Image Figure 17. Global Aquaporin Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Aquaporin Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Aquaporin Sales Value Share by Application (2021-2032) Figure 20. Global Aquaporin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Aquaporin Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Aquaporin Sales Value (2021-2032) & (US$ Million) Figure 23. North America Aquaporin Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Aquaporin Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Aquaporin Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Aquaporin Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Aquaporin Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Aquaporin Sales Value (2021-2032) & (US$ Million) Figure 29. South America Aquaporin Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Aquaporin Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Aquaporin Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Aquaporin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Aquaporin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Aquaporin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Aquaporin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Aquaporin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Aquaporin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Aquaporin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Aquaporin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Aquaporin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Aquaporin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Aquaporin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Aquaporin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Aquaporin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Aquaporin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Aquaporin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Aquaporin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Aquaporin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Aquaporin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Aquaporin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Aquaporin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Aquaporin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Aquaporin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Aquaporin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Aquaporin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Aquaporin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Aquaporin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Aquaporin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Aquaporin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Aquaporin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Aquaporin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Aquaporin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Aquaporin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Aquaporin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Aquaporin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Aquaporin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Aquaporin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Aquaporin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Aquaporin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Aquaporin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Aquaporin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Aquaporin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Aquaporin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Aquaporin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Aquaporin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Aquaporin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Aquaporin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Aquaporin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Aquaporin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Aquaporin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Aquaporin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Aquaporin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Aquaporin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Aquaporin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Aquaporin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Aquaporin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Aquaporin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Aquaporin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Aquaporin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Aquaporin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Aquaporin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Aquaporin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Aquaporin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Aquaporin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Aquaporin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Aquaporin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Aquaporin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Aquaporin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Aquaporin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Aquaporin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Aquaporin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Aquaporin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Aquaporin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Aquaporin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Aquaporin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Aquaporin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Aquaporin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Aquaporin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Aquaporin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Aquaporin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Aquaporin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Aquaporin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Aquaporin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Aquaporin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Aquaporin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Anti-Aquaporin Antibody
  • Aquaporin Channel Blocker
  • Other
Applications
  • Purification Of Water
  • Research
  • Medicine
  • Other
Companies covered
  • Merck KGaA
  • Santa Cruz Biotechnology
  • Proteintech Group
  • Boster Biological Technology
  • Bio-Techne
  • Bio-Rad Laboratories
  • Alomone Labs
  • Abcam
  • Abbexa

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Aquaporin Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Aquaporin Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Aquaporin Market Dynamics
  1. 2.1 Aquaporin Industry Trends
  2. 2.2 Aquaporin Industry Drivers
  3. 2.3 Aquaporin Industry Opportunities and Challenges
  4. 2.4 Aquaporin Industry Restraints
3 Aquaporin Market by Company
  1. 3.1 Global Aquaporin Company Revenue Ranking in 2025
  2. 3.2 Global Aquaporin Revenue by Company (2021-2026)
  3. 3.3 Global Aquaporin Company Ranking (2024-2026)
  4. 3.4 Global Aquaporin Company Manufacturing Base and Headquarters
  5. 3.5 Global Aquaporin Company Product Type and Application
  6. 3.6 Global Aquaporin Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Aquaporin Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Aquaporin Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Aquaporin Market by Type
  1. 4.1 Aquaporin Type Introduction
  2. 4.1.1 Anti-Aquaporin Antibody
  3. 4.1.2 Aquaporin Channel Blocker
  4. 4.1.3 Other
  5. 4.2 Global Aquaporin Sales Value by Type
  6. 4.2.1 Global Aquaporin Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Aquaporin Sales Value by Type (2021-2032)
  8. 4.2.3 Global Aquaporin Sales Value Share by Type (2021-2032)
5 Aquaporin Market by Application
  1. 5.1 Aquaporin Application Introduction
  2. 5.1.1 Purification Of Water
  3. 5.1.2 Research
  4. 5.1.3 Medicine
  5. 5.1.4 Other
  6. 5.2 Global Aquaporin Sales Value by Application
  7. 5.2.1 Global Aquaporin Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Aquaporin Sales Value by Application (2021-2032)
  9. 5.2.3 Global Aquaporin Sales Value Share by Application (2021-2032)
6 Aquaporin Regional Value Analysis
  1. 6.1 Global Aquaporin Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Aquaporin Sales Value by Region (2021-2032)
  3. 6.2.1 Global Aquaporin Sales Value by Region: 2021-2026
  4. 6.2.2 Global Aquaporin Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Aquaporin Sales Value (2021-2032)
  7. 6.3.2 North America Aquaporin Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Aquaporin Sales Value (2021-2032)
  10. 6.4.2 Europe Aquaporin Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Aquaporin Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Aquaporin Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Aquaporin Sales Value (2021-2032)
  16. 6.6.2 South America Aquaporin Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Aquaporin Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Aquaporin Sales Value Share by Country, 2025 VS 2032
7 Aquaporin Country-level Value Analysis
  1. 7.1 Global Aquaporin Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Aquaporin Sales Value by Country (2021-2032)
  3. 7.2.1 Global Aquaporin Sales Value by Country (2021-2026)
  4. 7.2.2 Global Aquaporin Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Aquaporin Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Aquaporin Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Aquaporin Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Aquaporin Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Aquaporin Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Aquaporin Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Aquaporin Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Aquaporin Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Aquaporin Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Aquaporin Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Aquaporin Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Aquaporin Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Aquaporin Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Aquaporin Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Aquaporin Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Aquaporin Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Aquaporin Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Aquaporin Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Aquaporin Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Aquaporin Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Aquaporin Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Aquaporin Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Aquaporin Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Aquaporin Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Aquaporin Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Aquaporin Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Aquaporin Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Aquaporin Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Aquaporin Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Aquaporin Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Aquaporin Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Aquaporin Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Aquaporin Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Aquaporin Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Aquaporin Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Aquaporin Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Aquaporin Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Aquaporin Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Aquaporin Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Aquaporin Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Aquaporin Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Aquaporin Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Aquaporin Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Aquaporin Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Aquaporin Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Aquaporin Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Aquaporin Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Aquaporin Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Aquaporin Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Aquaporin Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Aquaporin Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Aquaporin Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Aquaporin Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Aquaporin Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Aquaporin Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Aquaporin Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Aquaporin Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Aquaporin Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Aquaporin Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Aquaporin Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Aquaporin Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Aquaporin Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Aquaporin Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Aquaporin Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Aquaporin Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Aquaporin Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Aquaporin Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Aquaporin Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Aquaporin Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Aquaporin Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Aquaporin Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Aquaporin Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Aquaporin Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Aquaporin Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Aquaporin Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Aquaporin Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Aquaporin Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Aquaporin Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Aquaporin Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Aquaporin Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Aquaporin Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Aquaporin Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Aquaporin Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Aquaporin Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck KGaA
  2. 8.1.1 Merck KGaA Company Information
  3. 8.1.2 Merck KGaA Business Overview
  4. 8.1.3 Merck KGaA Aquaporin Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Merck KGaA Aquaporin Product Portfolio
  6. 8.1.5 Merck KGaA Recent Developments
  7. 8.2 Santa Cruz Biotechnology
  8. 8.2.1 Santa Cruz Biotechnology Company Information
  9. 8.2.2 Santa Cruz Biotechnology Business Overview
  10. 8.2.3 Santa Cruz Biotechnology Aquaporin Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Santa Cruz Biotechnology Aquaporin Product Portfolio
  12. 8.2.5 Santa Cruz Biotechnology Recent Developments
  13. 8.3 Proteintech Group
  14. 8.3.1 Proteintech Group Company Information
  15. 8.3.2 Proteintech Group Business Overview
  16. 8.3.3 Proteintech Group Aquaporin Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Proteintech Group Aquaporin Product Portfolio
  18. 8.3.5 Proteintech Group Recent Developments
  19. 8.4 Boster Biological Technology
  20. 8.4.1 Boster Biological Technology Company Information
  21. 8.4.2 Boster Biological Technology Business Overview
  22. 8.4.3 Boster Biological Technology Aquaporin Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Boster Biological Technology Aquaporin Product Portfolio
  24. 8.4.5 Boster Biological Technology Recent Developments
  25. 8.5 Bio-Techne
  26. 8.5.1 Bio-Techne Company Information
  27. 8.5.2 Bio-Techne Business Overview
  28. 8.5.3 Bio-Techne Aquaporin Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Bio-Techne Aquaporin Product Portfolio
  30. 8.5.5 Bio-Techne Recent Developments
  31. 8.6 Bio-Rad Laboratories
  32. 8.6.1 Bio-Rad Laboratories Company Information
  33. 8.6.2 Bio-Rad Laboratories Business Overview
  34. 8.6.3 Bio-Rad Laboratories Aquaporin Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Bio-Rad Laboratories Aquaporin Product Portfolio
  36. 8.6.5 Bio-Rad Laboratories Recent Developments
  37. 8.7 Alomone Labs
  38. 8.7.1 Alomone Labs Company Information
  39. 8.7.2 Alomone Labs Business Overview
  40. 8.7.3 Alomone Labs Aquaporin Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Alomone Labs Aquaporin Product Portfolio
  42. 8.7.5 Alomone Labs Recent Developments
  43. 8.8 Abcam
  44. 8.8.1 Abcam Company Information
  45. 8.8.2 Abcam Business Overview
  46. 8.8.3 Abcam Aquaporin Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Abcam Aquaporin Product Portfolio
  48. 8.8.5 Abcam Recent Developments
  49. 8.9 Abbexa
  50. 8.9.1 Abbexa Company Information
  51. 8.9.2 Abbexa Business Overview
  52. 8.9.3 Abbexa Aquaporin Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Abbexa Aquaporin Product Portfolio
  54. 8.9.5 Abbexa Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst